BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Scotland, UK.
Cardiovasc Drugs Ther. 2011 Feb;25(1):77-85. doi: 10.1007/s10557-011-6284-x.
We evaluated a generic quality of life (QoL) Functional Status Questionnaire (FSQ), in patients with chronic heart failure (CHF). The FSQ assesses the 3 main dimensions of QoL: physical functioning, mental health and social role. It also includes 6 single item questions about: work status, frequency of social interactions, satisfaction with sexual relationships, days in bed, days with restricted activity and overall satisfaction with health status. The FSQ was compared to the Minnesota Living with Heart Failure questionnaire (MLwHF).
The FSQ was evaluated in a substudy (n = 340) of the second Cardiac Insufficiency Bisoprolol Survival study (CIBIS-II), a placebo-controlled mortality trial. 265 patients (75%) patients completed both questionnaires at 6 months of follow-up. Both questionnaires indicated substantially impaired QoL. The FSQ demonstrated high internal consistency (Cronbach's α > 0.7 for all items except "social activity" = 0.66) and construct and concurrent validity. After 6 months, the only item on either questionnaire to show a difference between the placebo- and bisoprolol-treatment groups was the single item FSQ question about "days in bed" (p = 0.018 in favour of bisoprolol).
The FSQ performed well in this study, provided additional information to the MLwHF questionnaire and allowed interesting comparisons with other chronic medical conditions. The FSQ may be a useful general QoL instrument for studies in CHF.
我们评估了一种通用的生活质量(QoL)功能状态问卷(FSQ),用于慢性心力衰竭(CHF)患者。FSQ 评估了 QoL 的 3 个主要维度:身体功能、心理健康和社会角色。它还包括 6 个关于:工作状况、社交互动频率、性关系满意度、卧床天数、活动受限天数和整体健康满意度的单项问题。FSQ 与明尼苏达州心力衰竭生活质量问卷(MLwHF)进行了比较。
FSQ 在第二次心脏衰竭比索洛尔生存研究(CIBIS-II)的子研究(n=340)中进行了评估,这是一项安慰剂对照死亡率试验。265 名患者(75%)在 6 个月的随访中完成了这两个问卷。两个问卷都表明 QoL 严重受损。FSQ 表现出较高的内部一致性(除了“社会活动”项为 0.66 外,所有项目的 Cronbach's α>0.7)和结构和同时有效性。6 个月后,两个问卷中唯一一个在安慰剂和比索洛尔治疗组之间显示出差异的项目是 FSQ 关于“卧床天数”的单项问题(p=0.018,比索洛尔组更有利)。
FSQ 在这项研究中表现良好,为 MLwHF 问卷提供了额外的信息,并允许与其他慢性医疗条件进行有趣的比较。FSQ 可能是 CHF 研究中一种有用的通用 QoL 工具。